“You are very strong.” People say this as if it’s a compliment. Sometimes when I hear it, I smile back at them and mutter, “Thank…
Myeloma
Two combination therapies using Blenrep (belantamab mafodotin) — designed to treat adults with relapsed or refractory multiple myeloma — have been approved in the…
When I wake up in the morning, I do the same things in the same order: Examine the pillbox. Send a text to my mum…
Ichnos Glenmark Innovation (IGI) is partnering with Abbvie to advance the development of ISB 2001, a multiple myeloma treatment candidate that’s now in…
I have quite a lot of friends who are caregivers like me. Every day and night, they provide care, attention, and company to their patients,…
The U.S. Food and Drug Administration (FDA) has approved label updates for two Bristol Myers Squibb (BMS) CAR T-cell therapies, both for the treatment…
There is an unspoken rule that seems to apply to all cancer caregivers. It goes something like this: You should always be serious, present, and…
Linvoseltamab, now branded as Lynozyfic, has received accelerated approval from the U.S. Food and Drug Administration (FDA) for treating adults with relapsed or refractory…
I have 27 browser tabs open on my laptop and 33 on my phone. They range from grocery lists with foods low in sodium to…
A European Medicines Agency committee has recommended that Sarclisa (isatuximab), used in combination with standard-of-care medications, be approved for the treatment of adults newly…
